Company intelligence / Profile preview

LCY Chemical

Taipei, Taipei City, Taiwanlcycic.com ↗

Ownership: Private
Employees: ~1880
Development stage: Commercial

Overview

The company has shifted from commodity biochemicals like succinic acid to focus on nutraceuticals such as carotene, astaxanthin, and lycopene using large-scale fermentation. Some new bio-based pipeline products are in piloting/qualification stages. No clinical results as the company does not develop therapeutics.

Therapeutic areas: Metabolic DisordersOther
Modalities: Fermentation-based productsNutritional supplementsRenewable chemicals
Industry: Non-Drug Biotech

Partnerships

Bioindustrial Innovation CanadaLambton CollegeWestern Sarnia-Lambton Research Park

Beyond the preview

Go deeper on LCY Chemical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LCY Chemical.

Explore the full profile